Submitted by paige-dawkins on Mon, 30/04/2018 - 15:54
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Submitted by Nicola-Swanborough on Tue, 24/04/2018 - 11:44
Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.But the charity cautions that unless the regulations are backed by a public communications campaign, the long-fought-for measures may not reach those women and girls who have no option but to take the drug.
Information about and concerns around the anti-epileptic drug sodium valproate.
Submitted by Nicola-Swanborough on Fri, 23/03/2018 - 14:10
Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'
Submitted by paige-dawkins on Tue, 27/02/2018 - 15:59
Emma Friedmann is a parent carer of her 19 year old son who has fetal valproate syndrome. In February 2018, she attended parliament when the government announced their decision to review handling of concerns around sodium valproate.
Submitted by Nicola-Swanborough on Wed, 21/02/2018 - 18:30
Epilepsy Society's chief executive Clare Pelham has praised the Government's decision to announce a forward-looking review that will address the way the healthcare system has handled the concerns of patients in its care and make certain that lessons are learned and history does not repeat itself.
Submitted by Nicola-Swanborough on Mon, 12/02/2018 - 17:03
New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).
Submitted by Nicola-Swanborough on Tue, 06/02/2018 - 15:21
Epilepsy Society's chief executive Clare Pelham explains why mothers who have campaigned relentlessly about equality in women's health, are her inspiration as we celebrate #VotesforWomen
Submitted by Nicola-Swanborough on Thu, 26/10/2017 - 13:31
Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.
Submitted by Nicola-Swanborough on Wed, 18/10/2017 - 13:13
Arlene Foster, leader of the Democratic Unionist Party and First Minister of Northern Ireland has pledged her support for Epilepsy Society's campaign to ensure mandatory reviews for all women and girls of childbearing who take sodium valproate.